These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor. Bryce A; Ryan CJ Clin Pharmacol Ther; 2012 Jan; 91(1):101-8. PubMed ID: 22130117 [TBL] [Abstract][Full Text] [Related]
24. Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directions. Isaacsson Velho P; Carducci MA Expert Opin Investig Drugs; 2018 Oct; 27(10):811-822. PubMed ID: 30118330 [TBL] [Abstract][Full Text] [Related]
25. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
26. Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway. Mellado B; Codony J; Ribal MJ; Visa L; Gascón P Clin Transl Oncol; 2009 Jan; 11(1):5-10. PubMed ID: 19155198 [TBL] [Abstract][Full Text] [Related]
27. Androgen receptor as a target in androgen-independent prostate cancer. Balk SP Urology; 2002 Sep; 60(3 Suppl 1):132-8; discussion 138-9. PubMed ID: 12231070 [TBL] [Abstract][Full Text] [Related]
28. Alternative approaches to prevent androgen action in prostate cancer: are we there yet? Elbanna M; Heemers HV Discov Med; 2014 May; 17(95):267-74. PubMed ID: 24882718 [TBL] [Abstract][Full Text] [Related]
29. Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer. Zamagni A; Zanoni M; Cortesi M; Arienti C; Pignatta S; Naldini A; Sarnelli A; Romeo A; Tesei A Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182844 [TBL] [Abstract][Full Text] [Related]
30. Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer. Bedoya DJ; Mitsiades N Expert Rev Anticancer Ther; 2012 Jan; 12(1):1-3. PubMed ID: 22149426 [No Abstract] [Full Text] [Related]
31. Androgen receptor as a therapeutic target. Gao W Adv Drug Deliv Rev; 2010 Oct; 62(13):1277-84. PubMed ID: 20708648 [TBL] [Abstract][Full Text] [Related]
33. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells. Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473 [TBL] [Abstract][Full Text] [Related]
34. [Effect and adverse event of enzalutamide and abiraterone in prostate cancer]. Kosaka T; Oya M Nihon Rinsho; 2015 Feb; 73 Suppl 2():308-12. PubMed ID: 25831773 [No Abstract] [Full Text] [Related]
35. Androgen receptor antagonists for prostate cancer therapy. Helsen C; Van den Broeck T; Voet A; Prekovic S; Van Poppel H; Joniau S; Claessens F Endocr Relat Cancer; 2014 Aug; 21(4):T105-18. PubMed ID: 24639562 [TBL] [Abstract][Full Text] [Related]
36. New agents and strategies for the hormonal treatment of castration-resistant prostate cancer. Sharifi N Expert Opin Investig Drugs; 2010 Jul; 19(7):837-46. PubMed ID: 20524793 [TBL] [Abstract][Full Text] [Related]
37. AR, the cell cycle, and prostate cancer. Balk SP; Knudsen KE Nucl Recept Signal; 2008 Feb; 6():e001. PubMed ID: 18301781 [TBL] [Abstract][Full Text] [Related]
38. Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer. Sadar MD World J Urol; 2012 Jun; 30(3):311-8. PubMed ID: 21833557 [TBL] [Abstract][Full Text] [Related]
39. Androgen action and metabolism in prostate cancer. Green SM; Mostaghel EA; Nelson PS Mol Cell Endocrinol; 2012 Sep; 360(1-2):3-13. PubMed ID: 22453214 [TBL] [Abstract][Full Text] [Related]
40. Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer. Nguyen MM; Wang Z Minerva Urol Nefrol; 2008 Mar; 60(1):15-29. PubMed ID: 18427432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]